MSB 13.0% $1.31 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-11

  1. 6,445 Posts.
    lightbulb Created with Sketch. 2625
    How could I have ever doubted the integrity of Mr Silviu? wink.png

    Yeh, good call re wanting to release today.

    So we have revenue soon than expected. Had taken a large position on TA grounds from the recent huge volumes. Only way to play this company (for me) cause I don't trust jack coming out of CEO's mouth.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.